The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Sodium(1R,4S,5R)-1,4,5-Trihydroxy-3-(5-methylbenzo[b]-thiophen-2-yl)methoxycyclohexan-1-carboxylate ID: ALA567564
PubChem CID: 44627427
Max Phase: Preclinical
Molecular Formula: C17H17NaO6S
Molecular Weight: 350.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2sc(COC3=C[C@@](O)(C(=O)[O-])C[C@@H](O)[C@@H]3O)cc2c1.[Na+]
Standard InChI: InChI=1S/C17H18O6S.Na/c1-9-2-3-14-10(4-9)5-11(24-14)8-23-13-7-17(22,16(20)21)6-12(18)15(13)19;/h2-5,7,12,15,18-19,22H,6,8H2,1H3,(H,20,21);/q;+1/p-1/t12-,15+,17-;/m1./s1
Standard InChI Key: QDNKFBLMZXFZAX-NQLNPJAESA-M
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
4.2397 -2.7806 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
11.2016 -4.7608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2016 -5.5862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9141 -5.9948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6264 -5.5862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6264 -4.7608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9141 -4.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4934 -3.6269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3189 -3.6269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1443 -3.6190 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8993 -2.9160 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9141 -6.8202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4874 -6.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3406 -6.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7719 -5.5883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0577 -6.0020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3025 -5.6658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9719 -6.8214 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.1648 -6.9943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7562 -6.2813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9362 -6.2797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5240 -6.9904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9377 -7.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7562 -7.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6985 -6.9902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 13 1 0
5 6 1 0
5 14 1 1
6 7 1 0
13 15 1 0
15 16 1 0
16 17 2 0
7 8 1 6
17 20 1 0
19 18 1 0
18 16 1 0
7 9 1 0
2 3 2 0
19 20 2 0
9 10 1 0
20 21 1 0
2 7 1 0
21 22 2 0
9 11 2 0
22 23 1 0
3 4 1 0
23 24 2 0
24 19 1 0
4 12 1 6
22 25 1 0
4 5 1 0
M CHG 2 1 1 10 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 350.39Molecular Weight (Monoisotopic): 350.0824AlogP: 1.55#Rotatable Bonds: 4Polar Surface Area: 107.22Molecular Species: ACIDHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.99CX Basic pKa: ┄CX LogP: 1.09CX LogD: -2.07Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: 0.16
References 1. Prazeres VF, Tizón L, Otero JM, Guardado-Calvo P, Llamas-Saiz AL, van Raaij MJ, Castedo L, Lamb H, Hawkins AR, González-Bello C.. (2010) Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues., 53 (1): [PMID:19911771 ] [10.1021/jm9010466 ] 2. Tizón L, Otero JM, Prazeres VF, Llamas-Saiz AL, Fox GC, van Raaij MJ, Lamb H, Hawkins AR, Ainsa JA, Castedo L, González-Bello C.. (2011) A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors., 54 (17): [PMID:21780742 ] [10.1021/jm2006063 ]